ZSCAN12 and endometrial cancer: Herzog and colleagues, using cervical smear specimens obtained from 726 women with and without endometrial cancer, and validated in 562 cervico-vaginal fluid samples, identified a 3-marker assay for endometrial cancer detection based on DNA methylation changes in gene regions of GYPC and ZSCAN12.34